Cialis Tadalafil171596-29-5Sex Drug Male Sex Enhancer CAS NO.171596-29-5

1, High quality with competitive price: 1) Standard:BP/USP/EP/Enterprise standard 2) All Purity≥99% 3) We are manufacturer and can provide high quality products with factory price. 2, Fast and safe delivery 1) Parcel can be sent out in 24 hours after payment.Tracking number available 2) Secure and discreet shipment.Various transportation methods for your choice. 3) Customs pass rate ≥99% 4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe, and we have stock in there for transferring. 3,We have clients throughout the world. 1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire. 2) Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility. 3) High quality,competitive price,fast delivery ,first-class service gain the trust and praise from the customers.

Product: Name:Tadalafil(Male Sex Enhancer) CAS: 171596-29-5 Assay: 99% min. USP32 Packing: 1kg net/foil bag, 5kg/drum. Delivery: Express courier. Character: White to Off-White Cyrstalline Solid. Usage: Used for the treatment of erectile dysfunction. A phosphodiesterase 5 inhibitor. pharmaceutical material. Details: Tadalafil Citrate is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED) under the name , and under the name Adcirca for the treatment of pulmonary arterial hypertension,leads to smooth muscle relaxation, blood flows into the penile tissue, produce an erection, such as sexual stimulation. Applications: Although all work by inhibiting PDE5, tadalafil's pharmacologic distinction is its longer half-life (17.50 hours) - compared to (4.0-5.0 hours) and vardenafil (4.0-5.0 hours) - resulting in longer duration of action, and so partly responsible for "The Weekend Pill" sobriquet. Furthermore, the longer half-life is the basis for current investigation of tadalafil's daily therapeutic use in relieving pulmonary arterial hypertension. is approved in several world regions as a thrice-daily therapy for pulmonary arterial hypertension. COA: Item Standard Result Appearance White crystalline powder complies Melting Point 300°C ~303°C 301.5°C -302.5°C Loss on drying NMT 0.5% 0.23% Heavy metals(Pb) NMT 20ppm 6.0ppm Residue on ignition NMT 0.1% 0.08% Relative substance NMT 1.0% 0.17% Assay (on dried basis) NLT 98.5% 99.67% Conclusion Conforms with standard USP36